Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Basel Medical Group Ltd - SIC # 8081 -
Ticker
Exchange
SIC #
Website
Latest Ticker
BMGL
Nasdaq
8081
baselmedical.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Basel Medical Group Ltd
Receipt of Delinquency Notification from Nasdaq
- Jan 23rd, 2026 2:30 pm
Basel Medical Obtains Waiver of Lock-Up for Potential Strategic Fund Raising
- Jun 26th, 2025 2:15 pm
Basel Medical Group Ltd Reaffirms Strong Financial Position Amid Market Volatility
- May 29th, 2025 8:11 am
Basel Medical Group Subsidiary Awarded S$375 Million Contract to Supply Healthcare Products; Group to Enhance AI-Powered Healthcare Supply Chain Capabilities
- May 20th, 2025 7:20 am
Basel Medical Group Completes Acquisition of Bethesda Medical to Strengthen Healthcare Ecosystem in Singapore and Southeast Asia
- Apr 29th, 2025 10:15 pm
Basel Medical Group Signs Agreement to Acquire Bethesda Medical to Strengthen Healthcare Ecosystem in Singapore and Southeast Asia
- Apr 11th, 2025 12:30 am
Basel Medical Group Ltd Announces Exercise of Overallotment Option
- Mar 19th, 2025 2:10 pm
Basel Medical Group Ltd Announces Closing of US$8,820,000 Initial Public Offering
- Mar 3rd, 2025 2:00 am
Basel Medical Group Ltd Prices US$8,820,000 Initial Public Offering
- Feb 25th, 2025 3:08 pm
Why Basel Medical Group Ltd (NASDAQ:BMGL) Looks Like A Quality Company
- Feb 24th, 2025 12:31 pm
Scroll